JNJ - Company ID 0000200406
The table below shows JOHNSON & JOHNSON's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B | $82.58B |
| Cost of revenue | $30.26B | $27.47B | $26.55B | $24.60B | $23.40B | $28.43B |
| Gross profit | $63.94B | $61.35B | $58.61B | $55.39B | $55.34B | $54.16B |
| R&D | $109.00M | $1.84B | $483.00M | $0.00 | $0.00 | - |
JOHNSON & JOHNSON reported annual revenue of $94.19B for fiscal year 2025. That is up 6.0% from $88.82B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $71.89B (FY 2017) to $94.19B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $23.68B |
| $22.87B |
| $21.51B |
| $20.25B |
| $20.12B |
| $22.08B |
| Operating income | - | - | - | - | - | - |
| Income tax | $5.78B | $2.62B | $1.74B | $2.99B | $1.38B | $1.78B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B | $14.71B |
| EPS (diluted) | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 | $5.51 |